Amgen AMGN Cannot Overcome Confluence Resistance
A reader asked me to take a look at Amgen (AMGN) due to an interesting pattern he noticed. Let’s look at the recent “Rounded Reversal” as well as the failure at the confluence overhead resistance of the 200 day SMA and the 61.8% Fibonacci line.